- call +1-201-465-4211
- email sales@mrinsights.biz
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).
Scope of the Report:
In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016.
Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.
The worldwide market for Injectable Anticoagulants is expected to grow at a CAGR of roughly 2.7% over the next five years, will reach 6440 million US$ in 2024, from 5490 million US$ in 2019, according to a new study.
This report focuses on the Injectable Anticoagulants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other
Market Segment by Applications, can be divided into
VTE
ACS/MI
AF
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Injectable Anticoagulants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Injectable Anticoagulants, with price, sales, revenue and global market share of Injectable Anticoagulants in 2017 and 2018.
Chapter 3, the Injectable Anticoagulants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Injectable Anticoagulants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Injectable Anticoagulants market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Injectable Anticoagulants sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Injectable Anticoagulants Introduction
1.2 Market Analysis by Type
1.2.1 Low-molecular-weight Heparin (LMWH)
1.2.2 Direct Thrombin Inhibitor (DTI)
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 VTE
1.3.2 ACS/MI
1.3.3 AF
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Injectable Anticoagulants Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Genentech (Roche)
2.2.1 Business Overview
2.2.2 Injectable Anticoagulants Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Injectable Anticoagulants Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Injectable Anticoagulants Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 The Medicines Company
2.5.1 Business Overview
2.5.2 Injectable Anticoagulants Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 The Medicines Company Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Aspen
2.6.1 Business Overview
2.6.2 Injectable Anticoagulants Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Aspen Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Otsuka
2.7.1 Business Overview
2.7.2 Injectable Anticoagulants Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Otsuka Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Injectable Anticoagulants Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Injectable Anticoagulants Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Injectable Anticoagulants Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Injectable Anticoagulants Manufacturer Market Share in 2018
3.3.2 Top 6 Injectable Anticoagulants Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Injectable Anticoagulants Market Analysis by Regions
4.1 Global Injectable Anticoagulants Sales, Revenue and Market Share by Regions
4.1.1 Global Injectable Anticoagulants Sales and Market Share by Regions (2014-2019)
4.1.2 Global Injectable Anticoagulants Revenue and Market Share by Regions (2014-2019)
4.2 North America Injectable Anticoagulants Sales and Growth Rate (2014-2019)
4.3 Europe Injectable Anticoagulants Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Injectable Anticoagulants Sales and Growth Rate (2014-2019)
4.5 South America Injectable Anticoagulants Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Injectable Anticoagulants Sales and Growth Rate (2014-2019)
5 North America Injectable Anticoagulants by Country
5.1 North America Injectable Anticoagulants Sales, Revenue and Market Share by Country
5.1.1 North America Injectable Anticoagulants Sales and Market Share by Country (2014-2019)
5.1.2 North America Injectable Anticoagulants Revenue and Market Share by Country (2014-2019)
5.2 United States Injectable Anticoagulants Sales and Growth Rate (2014-2019)
5.3 Canada Injectable Anticoagulants Sales and Growth Rate (2014-2019)
5.4 Mexico Injectable Anticoagulants Sales and Growth Rate (2014-2019)
6 Europe Injectable Anticoagulants by Country
6.1 Europe Injectable Anticoagulants Sales, Revenue and Market Share by Country
6.1.1 Europe Injectable Anticoagulants Sales and Market Share by Country (2014-2019)
6.1.2 Europe Injectable Anticoagulants Revenue and Market Share by Country (2014-2019)
6.2 Germany Injectable Anticoagulants Sales and Growth Rate (2014-2019)
6.3 UK Injectable Anticoagulants Sales and Growth Rate (2014-2019)
6.4 France Injectable Anticoagulants Sales and Growth Rate (2014-2019)
6.5 Russia Injectable Anticoagulants Sales and Growth Rate (2014-2019)
6.6 Italy Injectable Anticoagulants Sales and Growth Rate (2014-2019)
7 Asia-Pacific Injectable Anticoagulants by Country
7.1 Asia-Pacific Injectable Anticoagulants Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Injectable Anticoagulants Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Injectable Anticoagulants Revenue and Market Share by Country (2014-2019)
7.2 China Injectable Anticoagulants Sales and Growth Rate (2014-2019)
7.3 Japan Injectable Anticoagulants Sales and Growth Rate (2014-2019)
7.4 Korea Injectable Anticoagulants Sales and Growth Rate (2014-2019)
7.5 India Injectable Anticoagulants Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Injectable Anticoagulants Sales and Growth Rate (2014-2019)
8 South America Injectable Anticoagulants by Country
8.1 South America Injectable Anticoagulants Sales, Revenue and Market Share by Country
8.1.1 South America Injectable Anticoagulants Sales and Market Share by Country (2014-2019)
8.1.2 South America Injectable Anticoagulants Revenue and Market Share by Country (2014-2019)
8.2 Brazil Injectable Anticoagulants Sales and Growth Rate (2014-2019)
8.3 Argentina Injectable Anticoagulants Sales and Growth Rate (2014-2019)
8.4 Colombia Injectable Anticoagulants Sales and Growth Rate (2014-2019)
9 Middle East and Africa Injectable Anticoagulants by Countries
9.1 Middle East and Africa Injectable Anticoagulants Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Injectable Anticoagulants Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Injectable Anticoagulants Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Injectable Anticoagulants Sales and Growth Rate (2014-2019)
9.3 Turkey Injectable Anticoagulants Sales and Growth Rate (2014-2019)
9.4 Egypt Injectable Anticoagulants Sales and Growth Rate (2014-2019)
9.5 Nigeria Injectable Anticoagulants Sales and Growth Rate (2014-2019)
9.6 South Africa Injectable Anticoagulants Sales and Growth Rate (2014-2019)
10 Global Injectable Anticoagulants Market Segment by Type
10.1 Global Injectable Anticoagulants Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Injectable Anticoagulants Sales and Market Share by Type (2014-2019)
10.1.2 Global Injectable Anticoagulants Revenue and Market Share by Type (2014-2019)
10.2 Low-molecular-weight Heparin (LMWH) Sales Growth and Price
10.2.1 Global Low-molecular-weight Heparin (LMWH) Sales Growth (2014-2019)
10.2.2 Global Low-molecular-weight Heparin (LMWH) Price (2014-2019)
10.3 Direct Thrombin Inhibitor (DTI) Sales Growth and Price
10.3.1 Global Direct Thrombin Inhibitor (DTI) Sales Growth (2014-2019)
10.3.2 Global Direct Thrombin Inhibitor (DTI) Price (2014-2019)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2014-2019)
10.4.2 Global Other Price (2014-2019)
11 Global Injectable Anticoagulants Market Segment by Application
11.1 Global Injectable Anticoagulants Sales Market Share by Application (2014-2019)
11.2 VTE Sales Growth (2014-2019)
11.3 ACS/MI Sales Growth (2014-2019)
11.4 AF Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Injectable Anticoagulants Market Forecast (2019-2024)
12.1 Global Injectable Anticoagulants Sales, Revenue and Growth Rate (2019-2024)
12.2 Injectable Anticoagulants Market Forecast by Regions (2019-2024)
12.2.1 North America Injectable Anticoagulants Market Forecast (2019-2024)
12.2.2 Europe Injectable Anticoagulants Market Forecast (2019-2024)
12.2.3 Asia-Pacific Injectable Anticoagulants Market Forecast (2019-2024)
12.2.4 South America Injectable Anticoagulants Market Forecast (2019-2024)
12.2.5 Middle East and Africa Injectable Anticoagulants Market Forecast (2019-2024)
12.3 Injectable Anticoagulants Market Forecast by Type (2019-2024)
12.3.1 Global Injectable Anticoagulants Sales Forecast by Type (2019-2024)
12.3.2 Global Injectable Anticoagulants Market Share Forecast by Type (2019-2024)
12.4 Injectable Anticoagulants Market Forecast by Application (2019-2024)
12.4.1 Global Injectable Anticoagulants Sales Forecast by Application (2019-2024)
12.4.2 Global Injectable Anticoagulants Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Injectable Anticoagulants Picture
Table Product Specifications of Injectable Anticoagulants
Figure Global Sales Market Share of Injectable Anticoagulants by Types in
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
